artesunic acid has been researched along with acetylcysteine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brittenham, G; Carroll, J; Krudsood, S; Kuhn, WF; Looareesuwan, S; Maek-A-Nantawat, W; Saengnetswang, T; Tosukhowong, T; Treeprasertsuk, S; Vannaphan, S | 1 |
| Arreesrisom, P; Dondorp, AM; Looareesuwan, S; Udomsangpetch, R | 1 |
| Efferth, T; Giaisi, M; Krammer, PH; Li-Weber, M; Merling, A | 1 |
| Abul Faiz, M; Bin Yunus, E; Charunwatthana, P; Day, NP; Dondorp, AM; Hasan, MU; Hoque, MG; Lee, SJ; Maude, RJ; Moore, K; Newton, PN; Pukrittayakamee, S; Rahman, MR; Roberts, LJ; Ruangveerayut, R; White, NJ | 1 |
| Beccafico, S; Donato, R; Marchetti, MC; Morozzi, G; Riccardi, C; Sidoni, A; Sorci, G | 1 |
| Azevedo, C; Brindley, PJ; da Costa, JMC; Gärtner, F; Gouveia, MJ; Vale, N | 1 |
2 trial(s) available for artesunic acid and acetylcysteine
| Article | Year |
|---|---|
N-acetylcysteine in severe falciparum malaria in Thailand.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Survival Rate; Thailand; Treatment Outcome | 2003 |
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
Topics: Acetylcysteine; Adult; Antimalarials; Artemisinins; Artesunate; Bangladesh; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Placebos; Thailand; Treatment Outcome | 2009 |
4 other study(ies) available for artesunic acid and acetylcysteine
| Article | Year |
|---|---|
Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.
Topics: Acetylcysteine; Animals; Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Interactions; Humans; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Antimalarials; Apoptosis; Artemisinins; Artesunate; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Free Radical Scavengers; Humans; Leukemia; Mice; Oxidation-Reduction; Reactive Oxygen Species | 2007 |
Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Integrin beta1; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; Neural Cell Adhesion Molecules; p38 Mitogen-Activated Protein Kinases; PAX7 Transcription Factor; Pyridines; Reactive Oxygen Species; Rhabdomyosarcoma, Embryonal; Transplantation, Heterologous | 2015 |
The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni.
Topics: Acetylcysteine; Animals; Antioxidants; Antiprotozoal Agents; Artesunate; Biomphalaria; Drug Synergism; Female; Larva; Male; Plant Extracts; Praziquantel; Resveratrol; Schistosoma mansoni; Schistosomiasis | 2019 |